Expanded capabilities Leverage Eurofins Viracor BioPharma Services broad platform agility and 40+ technology platforms to offer bespoke assay development and validation services across diverse therapeutic areas, appealing to sponsors seeking flexible, end-to-end testing solutions.

High throughput readiness Highlight rapid turnaround and scalable processing capacity to meet Phase 1–4 trial timelines, positioning as a reliable partner for larger trials and studies requiring quick ramp-up and integrated project management.

Vaccine and infectious disease strength Emphasize expertise in molecular infectious disease testing, vaccine safety/ efficacy assessment, and biomarker analysis to attract clients in infectious disease programs, immunotherapies, and vaccine development pipelines.

Custom assay development Promote the ongoing development of new custom assays and a validated list of over 3,000 assays, signaling capacity to tailor tests to unique study endpoints and regulatory requirements.

Global and scalable footprint Point to regional facility expansions and access to multiple specimen types and technology platforms to support multi-country trials, regulatory submissions, and supply chain diversification for sponsors seeking global CRO partnerships.